List of Publications

Vanessa M. Beutgen

Ordered by date

  1. TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion.
    Steitz, A.M., Schröder, C., Knuth, I., Keber, C.U., Sommerfeld, L., Finkernagel, F., Jansen, J.M., Wagner, U., Müller-Brüsselbach, S., Worzfeld, T., Huber, M., Beutgen, V.M., Graumann, J., Pogge Von Strandmann, E., Müller, R., and Reinartz, S.
    iScience
    2023. Online ahead of print
    DOI: 10.1016/j.isci.2023.108401

  2. Association of autoantibody levels with different stages of age-related macular degeneration (AMD): Results from the population-based Gutenberg Health Study (GHS).
    Korb, C.A., Lackner, K.J., Wolters, D., Schuster, A.K., Nickels, S., Beutgen, V.M., Münzel, T., Wild, P.S., Beutel, M.E., Schmidtmann, I., Pfeiffer, N., and Grus, F.H.
    Graefe’s Archive for Clinical and Experimental Ophthalmology
    2023. Online ahead of print
    DOI: 10.1007/s00417-023-06085-2

  3. Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1.
    Fomo, K.N., Schmelter, C., Atta, J., Beutgen, V.M., Schwarz, R., Perumal, N., Govind, G., Speck, T., Pfeiffer, N., and Grus, F.H.
    Frontiers in Medicine
    2022. 9, 993351
    DOI: 10.3389/fmed.2022.993351

  4. A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma.
    Tonner, H., Hunn, S., Auler, N., Schmelter, C., Beutgen, V.M., von Pein, H.D., Pfeiffer, N., and Grus, F.H.
    International Journal of Molecular Sciences
    2022. 23(8), 4107
    DOI: 10.3390/ijms23084107

  5. Contribution of the Commensal Microflora to the Immunological Homeostasis and the Importance of Immune-Related Drug Development for Clinical Applications.
    Beutgen, V.M., Schmelter, C., Pfeiffer, N., and Grus, F.H.
    International Journal of Molecular Sciences
    2021. 22(16), 8896
    DOI: 10.3390/ijms22168896

  6. Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.
    Beutgen, V.M., Pfeiffer, N., and Grus, F.H.
    Frontiers in Immunology
    2021. 12, 616421
    DOI: 10.3389/fimmu.2021.616421

  7. Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients.
    Bell, K., Beutgen, V.M., Nickels, S., Lorenz, K., Scheller, Y., Elbaz, H., Peto, T., Ponto, K.A., Schulz, A., Wild, P.S., Münzel, T., Lackner, K.J., Schmidtmann, I., Beutel, M., Pfeiffer, N., Grus, F.H., and Schuster, A.K.
    Journal of Ophthalmology
    2020. 2020, 8386160
    DOI: 10.1155/2020/8386160

  8. Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire.
    Beutgen, V.M., Schmelter, C., Pfeiffer, N., and Grus, F.H.
    Clinical & Translational Immunology
    2020. 9(3), e01101
    DOI: 10.1002/cti2.1101

  9. An In-Depth View of the Porcine Trabecular Meshwork Proteome.
    Funke, S., Beutgen, V.M., Bechter, L., Schmelter, C., Zurawski, V., Perumal, N., Pfeiffer, N., and Grus, F.H.
    International Journal of Molecular Sciences
    2019. 20(10), E2526
    DOI: 10.3390/ijms20102526

  10. Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA).
    Beutgen, V.M., Perumal, N., Pfeiffer, N., and Grus, F.H.
    Frontiers in Immunology
    2019. 10, 381
    DOI: 10.3389/fimmu.2019.00381